S Hardikar
Overview
Explore the profile of S Hardikar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhosale A, Hardikar S, Pathak A, Sable R
Indian J Pharm Sci
. 2010 May;
71(3):320-2.
PMID: 20490304
Ayurvedic powders are widely used as therapeutic agents but most of them have unpleasant taste and large doses. One of the possible approach to overcome these drawbacks is to represent...
2.
Yang N, Venugopalan M, Hardikar S, Glasebrook A
Science
. 1997 Feb;
275(5304):1249.
PMID: 9064777
No abstract available.
3.
Yang N, Venugopalan M, Hardikar S, Glasebrook A
Science
. 1996 Aug;
273(5279):1222-5.
PMID: 8703055
17beta-Estradiol modulates gene transcription through the estrogen receptor and the estrogen response element in DNA. The human transforming growth factor-beta3 gene was shown to be activated by the estrogen receptor...
4.
Yang N, Bryant H, Hardikar S, Sato M, Galvin R, Glasebrook A, et al.
Endocrinology
. 1996 May;
137(5):2075-84.
PMID: 8612550
Estrogen or raloxifene (LY156758) prevent estrogen deficiency-induced bone loss in animals and humans. We demonstrated in the rat that a 22% reduction in bone mineral density generated by ovariectomy was...
5.
Taylor K, Shetta M, Talpaz M, Kantarjian H, Hardikar S, Chinault A, et al.
Leukemia
. 1989 Jun;
3(6):419-22.
PMID: 2566725
Myeloproliferative disorders are neoplasms of the pluripotent hematopoietic stem cell. Accurate diagnosis and distinction from reactive processes can be difficult therein with cytogenetic analysis only being useful in a minority...